Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells

被引:3
作者
George Kolios
Vassilis Valatas
Pinelopi Manousou
Costas Xidakis
George Notas
Elias Kouroumalis
机构
[1] University of Crete,Department of Gastroenterology, Faculty of Medicine
来源
Molecular and Cellular Biochemistry | 2008年 / 319卷
关键词
Nitric oxide; MCP-1; Chemokine(s); Kupffer cells; Sinusoidal cell(s); Liver;
D O I
暂无
中图分类号
学科分类号
摘要
Nitric oxide (NO) and Monocyte Chemoattractant Protein (MCP)-1 co-regulation has been found in endotoxin-activated macrophages. Kupffer cells (KC) are a main source of soluble-mediators production in liver abnormalities. We investigated in vitro similar co-regulation of NO and MCP-1 production in rat activated KC. Isolated rat KC were cultured in the presence of 1 μg/ml LPS and various concentrations of Wortmannin (0–300 nM), L-NAME (0–500 μM) or MCP-1 (0–100 ng/ml). Production of MCP-1 and NO were measured in supernatants, by ELISA and a modification of the Griess reaction, respectively. Growth arrested KC, stimulated with vehicle, produced a basal amount of NO and MCP-1. In the presence of LPS, cultured KC secreted significantly (P < 0.01) increased amounts of MCP-1 and NO. Pre-treatment of KC with various concentrations of L-NAME significantly (P < 0.05) reduced the LPS-induced secretion of NO in a concentration dependent manner, but the MCP-1 production remained unaffected. Pre-treatment with Wortmannin significantly (P < 0.05) inhibited LPS-induced secretion of MCP-1 and NO in a concentration dependent manner. Linear regression analysis revealed a positive correlation between MCP-1 and NO in the LPS (r = 0.59171, P < 0.0001) and Wortmannin (r = 0.9215, P = 0.009) treated groups, but not in the L-NAME (r = −0.08513, P = 0.873). Incubation of KC with various concentrations of MCP-1 did not increase the NO production. These results indicate that KC might be the main source of NO and MCP-1 production in liver disorders, probably through the induction of PI3-kinase(s) and without any co-regulation between these molecules, which might represent two independent immunoregulatory pathways in the role of KC in hepatic disorders.
引用
收藏
页码:91 / 98
页数:7
相关论文
共 244 条
[1]
Kolios G(2006)Role of Kupffer cells in the pathogenesis of liver disease World J Gastroenterol 12 7413-7420
[2]
Valatas V(2002)Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation Am J Physiol Gastrointest Liver Physiol 283 G256-G265
[3]
Kouroumalis E(1995)Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia Shock 3 56-62
[4]
Su GL(2002)Intestinal endotoxemia as a pathogenetic mechanism in liver failure World J Gastroenterol 8 961-965
[5]
Liu P(1991)Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 109-142
[6]
McGuire GM(2004)Nitric oxide biology and the liver: report of an AASLD research workshop Hepatology 39 250-257
[7]
Fisher MA(2001)Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice J Clin Invest 107 439-447
[8]
Farhood A(2001)Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge Am J Physiol Gastrointest Liver Physiol 281 G173-G181
[9]
Smith CW(2006)The many roles of chemokines and chemokine receptors in inflammation N Engl J Med 354 610-621
[10]
Jaeschke H(2000)The role of chemokines in the immunopathology of the liver Immunol Rev 177 8-20